Rio Tinto (ADR) vs Vir Biotechnology Inc. Common Stock — how do they compare? Rio Tinto (ADR) trades at $88.48 (market cap $149.24B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Rio Tinto (ADR) is far larger — about 84.8× Vir Biotechnology Inc. Common Stock's market cap, and Rio Tinto (ADR) pays a 5.1% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rio Tinto (ADR) for 12 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| RIO | VIR | |
|---|---|---|
Market Cap | $149.24B | $1.76B |
Volume | 2,122,105 | 2,764,948 |
Sector | Basic Materials | Health |
52-Week High | $112.04 | $11.78 |
52-Week Low | $67.89 | $5.12 |
Typical Hold Time | 12 Days | 0 Days |
Enterprise Value | $162.59B | $1.32B |
Dividend Yield | 5.1% | — |
Signals from Pluang's Aura AI — not financial advice
Rio Tinto (RIO) trades at $93.06, down 1.31% on the day, with mixed technical signals showing bearish moving averages but neutral oscillators. Fundamentally, the company demonstrates strong profitability with 19.58% net income margin and 19.57% ROE, supported by recent quarterly earnings beats. Recent news highlights operational strength with 27% copper production growth at Oyu Tolgoi and maintained 2026 guidance.
The stock presents a compelling value opportunity with a 12.61 P/E ratio trading below the $103.13 consensus target. However, bearish technical momentum and legal risks from Madagascar contamination claims warrant caution. Analyst sentiment is mixed with 35% buy ratings versus 23% sell recommendations, suggesting balanced risk-reward for long-term investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.
Read more on RIO →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →